Targeting epidermal Langerhans cells by epidermal powder immunization

Cell Research

Volumn 12, Issue 2, 2002, Pages 97-104

  Chen, Dexiang ^a   Payne, Lendon G ^a  

^a PowderJect Vaccines Inc   (United States)

Author keywords

Dendritic cells; Epidermal immunization; Langerhans cells; Vaccines

Indexed keywords

HARNESS;

VACCINE;

ANIMAL; ANTIGEN PRESENTING CELL; CYTOLOGY; EPIDERMIS; HUMAN; IMMUNIZATION; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; LANGERHANS CELL; METABOLISM; METHODOLOGY; PHYSIOLOGY; POWDER; REVIEW;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIGEN-PRESENTING CELLS; EPIDERMIS; HUMANS; IMMUNIZATION; LANGERHANS CELLS; POWDERS; VACCINES;

EID: 0036597928     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290115     Document Type: Review

References (50)

1. Chen H, Yuan J, Wang Y, and Silvers WK. Distribution of ATPase-positive Langerhans cells in normal adult skin. Br J Dermatol 1985; 113:707-11.
2. Berman B, Chen VL, France DS, Dotz WI, Petroni, G. Anatomical mapping of epidermal Langerhans cell density in adults. Br J Dermatol 1983; 109(5):553-8.
3. Bos JD, Zonneveld I, Das PK, Krieg SR, van der Loos CM, Kapsenberg ML. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 1987; 88(5):569-73.
4. Teunissen MB. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells. Histochem J 1992; 24(10):697-716.
5. Romani N, Ratzinger G, Pfaller K, Salvenmoser W, Stossel H, Koch F, Stoitzner P. Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. Int Rev Cytol 2001; 207:237-70.
6. Gordyal P, Isaacson PG. Immunocytochemical characterization of monocyte colonies of human bone marrow: a clue to the origin of Langerhans cells and interdigitating reticulum cells. J Pathol 1985; 146(3):189-95.
7. Dezutter-Dambuyant C, Schmitt D, Faure M, Cordier G, Thivolet J. Detection of OKT6-positive cells (without visible Birbeck granules) in normal peripheral blood. Immunol Lett 1984; 8(3):121-6.
8. Jakob T, Ring J, Udey MC. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 2001; 108(5): 688-96.
9. Pieri L, Domenici L, Romagnoli P. Langerhans cells differentiation: a three-act play. Ital J Anat Embryol 2001; 106(1):47-69.
10. Romani N, Ratzinger G, Pfaller K, Salvenmoser W, Stossel H, Koch F, Stoitzner P. Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. Int Rev Cytol 2001; 207:237-70.
11. Wang B, Amerio P, Sauder DN. Role of cytokines in epidermal Langerhans cell migration. J Leukoc Biol 1999; 66(1):33-9.
12. Cruz PD Jr, Bergstresser PR. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness. Dermatol Clin 1990; 8(4):633-47.
13. Romani N, Koide S, Crowley M, Witmer-Pack M, Livingstone AM, Fathman CG, Inaba K, Steinman RM. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989; 169(3):1169-78.
14. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985; 161(3):526-46.
15. Timares L, Takashima A, Johnston SA: Quantitative analysis of the immunopotency of genetically transfected dentritic cells. Proc Natl Acad Sci USA 1998; 96:13147-52.
16. McKinney EC, Streilein LM: On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J Immunol 1989; 143:1560-4.
17. Schroder JM. Cytokine networks in the skin. J Invest Dermatol 1995; 105(1 Suppl):20S-4S.
18. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O'Keeffe M. Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 2001; 166(9):5448-55.
19. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997; 159(1):28-35.
20. De Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 1997; 27(5):1229-35.
21. Reider N, Reider D, Ebner S, Holzmann S, Herold M, Fritsch P, Romani N. Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. J Allergy Clin Immunol 2002; 109:89-95.
22. Banchereau, J Steinman RM. Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52.
23. Sprecher E, Becker Y. Role of Langerhans cells and other dendritic cells in viral diseases. Arch Virol 1993; 132(1-2):1-28.
24. Williams NA, Hill TJ, Hooper DC. Murine epidermal antigen-presenting cells in primary and secondary T-cell proliferative responses to herpes simplex virus in vitro. Immunology. 1991; 72(1):34-9.
25. Otani T, Mori R. The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection. Arch Virol 1987; 96(1-2):1-15.
26. Sprecher E, Becker Y. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch Virol 1989; 107(3-4):191-205.
27. Xu H, Bjarnason B, Elmets CA. Sensitization versus elicitation in allergic contact dermatitis: potential differences at cellular and molecular levels. Am J Contact Dermat 2000; 11(4):228-34.
28. Kimber I, Dearman RJ, Cumberbatch M, Huby RJ. Langerhans cells and chemical allergy. Curr Opin Immunol 1998; 10(6):614-9.
29. Tsuruta D, Kaneda K, Teramae H, Ishii M. In vivo activation of Langerhans cells and dendritic epidermal T cells in the elicitation phase of murine contact hypersensitivity. Br J Dermatol 1999; 140(3):392-9.
30. Holgate ST. The epidemic of allergy and asthma. Nature 1999; 402(6760 Suppl):B2-4.
31. von Bubnoff D, Geiger E, Bieber T. Antigen-presenting cells in allergy. J Allergy Clin Immunol 2001; 108(3):329-39.
32. Lambrecht BN, Hoogsteden HC, Pauwels RA. Dendritic cells as regulators of the immune response to inhaled allergen: recent findings in animal models of asthma. Int Arch Allergy Immunol 2001; 124(4):432-46.
33. Meunier L, Raison-Peyron N, Meynadier J. UV-induced immunosuppression and skin cancers. Rev Med Interne 1998; 19(4):247-54.
34. Muller HK, Dandie GW, Ragg SJ, Woods GM. Langerhans cell alterations in cutaneous carcinogenesis. In Vivo 1993; 7(3):293-6.
35. Miyagi J, Kinjo T, Tsuhako K, Higa M, Iwamasa T, Kamada Y, Hirayasu T. Extremely high Langerhans cell infiltration contributes to the favourable prognosis of HPV-infected squamous cell carcinoma and adenocarcinoma of the lung. Histopathology. 2001; 38(4):355-67.
36. Johnson SK, Kerr KM, Chapman AD, Kennedy MM, King G, Cockburn JS, Jeffrey RR. Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer 2000; 27(1):27-35.
37. Kumamoto T, Morita A, Takashima A. Recent advances in dendritic cell vaccines for cancer treatment. J Dermatol 2001; 28(11):658-62.
38. Nouri-Shirazi M, Banchereau J, Fay J, Palucka K. Dendritic cell based tumor vaccines. Immunol Lett 2000; 74(1):5-10.
39. Hammond SA, Guebre-Xabier M, Yu J, Glenn GM. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy. Crit Rev Ther Drug Carrier Syst 2001; 18(5):503-26.
40. Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000; 6(12):1403-6.
41. Johnston SA, Anziano PQ, Shark K, Sanford JC, Butow RA. Mitochondrial transformation in yeast by bombardment with microprojectiles. Science. 1988; 240(4858):1538-41.
42. Ye GN, Daniell H, Sanford JC. Optimization of delivery of foreign DNA into higher-plant chloroplasts. Plant Mol Biol 1990; 15(6):809-19.
43. Williams RS, Johnston SA, Riedy M, DeVit MJ, McElligott SG, Sanford JC. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci USA 1991; 88(7):2726-30.
44. Chen D, Endres RL, Erickson CA, Weis KF, McGregor MW, Kawaoka Y, Payne LG. Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice. Nat Med 2000; 6:1187-90.
45. Chen D, Erickson CA, Endres RL, Periwal SB, Chu Q, Shu C, Maa YF, Payne LG. Adjuvantation of epidermal powder immunization. Vaccine 2001; 19:2908-17.
46. Chen D, Periwal SB, Larrivee K, Zuleger C, Erickson CA, Endres RL, Payne LG. Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization. J Virol 2001; 75:7956-65.
47. Chen D, Weis KF, Chu Q, Erickson C, Endres R, Lively CR, Osorio J, Payne LG. Epidermal powder immunization induces both cytotoxic T lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses. J Virol 2001; 75:1630-40.
48. Chen D, Zuleger C, Chu Q, Maa YF, Osorio J, Payne, LG. Epidermal Powder Immunization with a Recombinant HIV gp120 Targets Langerhans Cells and Induces both Antibody and Cellular Immune Responses. Submitted to AIDS Research and Human Retroviruses.
49. Moingeon P. Cancer vaccines. Vaccine 2001; 19:1305-26.
50. Wohlleben G, Erb KJ. Barnes P. Atopic disorders: a vaccine around the corner? Trends Immunol 2001; 22(11):618-26.